Cargando…
COVID-19 vaccination side effects among the child age group: a large cross-sectional online based survey in Saudi Arabia
BACKGROUND: Multiple vaccines have been tested in clinical trials for their efficacy and safety. In Saudi Arabia, Pfizer–BioNTech or Moderna were approved for children, however, previous studies to report their safety profile are limited. This research aims to understand the side effect of children&...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724422/ https://www.ncbi.nlm.nih.gov/pubmed/36474174 http://dx.doi.org/10.1186/s12879-022-07905-2 |
_version_ | 1784844412066463744 |
---|---|
author | Alwafi, Hassan Naser, Abdallah Y. Aldhahir, Abdulelah M. Alhazmi, Ahmad Alosaimi, Areen Naif Mandili, Rasha Abdulaziz Majeed, Zaid Salawati, Emad Ekram, Rakan Samannodi, Mohammed Assaggaf, Hamza Almatrafi, Mohammed Alqahtani, Jaber S. Alsanosi, Safaa Mohammed Minshawi, Faisal |
author_facet | Alwafi, Hassan Naser, Abdallah Y. Aldhahir, Abdulelah M. Alhazmi, Ahmad Alosaimi, Areen Naif Mandili, Rasha Abdulaziz Majeed, Zaid Salawati, Emad Ekram, Rakan Samannodi, Mohammed Assaggaf, Hamza Almatrafi, Mohammed Alqahtani, Jaber S. Alsanosi, Safaa Mohammed Minshawi, Faisal |
author_sort | Alwafi, Hassan |
collection | PubMed |
description | BACKGROUND: Multiple vaccines have been tested in clinical trials for their efficacy and safety. In Saudi Arabia, Pfizer–BioNTech or Moderna were approved for children, however, previous studies to report their safety profile are limited. This research aims to understand the side effect of children's vaccination against SARS-CoV-2 infection in Saudi Arabia. METHODS: This was an observational retrospective cross-sectional study was conducted using an online survey in Saudi Arabia from March to May 2022. The inclusion criteria were parents aged 18 years and above who live in Saudi Arabia and have vaccinated their children. The self-reported questionnaire was adopted from published studies to investigate the study objectives Descriptive statistics were used to describe patients’ demographic characteristics, continuous data were reported as mean ± S.D., categorical data were reported as percentages (frequencies), and logistic regression was used to identify predictors of persistent post-COVID-19 symptoms. RESULTS: This study had a total of 4,069 participants. Only 41.9% of the participants reported that their child(ren) had been infected with the coronavirus. 2.00 was the median number of children (IQR: 1.00–4.00). More than half of the study participants (64.2%) reported that a family member had been infected with the coronavirus. Both parents received COVID-19 vaccination, according to most participants (88.7%). Most participants (70.5%) stated that all children who met the vaccination criteria had received the vaccine. Most participants (83.5%) said their child or children had two doses of their vaccine, and about half (50.4%) of those who received the vaccine reported experiencing side effects. In addition, the majority (78.9%) reported that the side effects appeared within one day of receiving the vaccine, and nearly two-thirds (65.7%) reported that the side effects lasted between one and three. A total of 11,831 side effects cases were documented. Pain at the injection site, hyperthermia, and fatigue were the most reported side effects, accounting for 15.3%, 14.1%, and 13.2%, respectively. CONCLUSION: It appears that the side effects of the COVID-19 vaccine for children are minor, tolerable, and like those described previously in clinical trials. Our data should encourage the public about the safety of receiving the COVID-19 vaccine for children. |
format | Online Article Text |
id | pubmed-9724422 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-97244222022-12-07 COVID-19 vaccination side effects among the child age group: a large cross-sectional online based survey in Saudi Arabia Alwafi, Hassan Naser, Abdallah Y. Aldhahir, Abdulelah M. Alhazmi, Ahmad Alosaimi, Areen Naif Mandili, Rasha Abdulaziz Majeed, Zaid Salawati, Emad Ekram, Rakan Samannodi, Mohammed Assaggaf, Hamza Almatrafi, Mohammed Alqahtani, Jaber S. Alsanosi, Safaa Mohammed Minshawi, Faisal BMC Infect Dis Research BACKGROUND: Multiple vaccines have been tested in clinical trials for their efficacy and safety. In Saudi Arabia, Pfizer–BioNTech or Moderna were approved for children, however, previous studies to report their safety profile are limited. This research aims to understand the side effect of children's vaccination against SARS-CoV-2 infection in Saudi Arabia. METHODS: This was an observational retrospective cross-sectional study was conducted using an online survey in Saudi Arabia from March to May 2022. The inclusion criteria were parents aged 18 years and above who live in Saudi Arabia and have vaccinated their children. The self-reported questionnaire was adopted from published studies to investigate the study objectives Descriptive statistics were used to describe patients’ demographic characteristics, continuous data were reported as mean ± S.D., categorical data were reported as percentages (frequencies), and logistic regression was used to identify predictors of persistent post-COVID-19 symptoms. RESULTS: This study had a total of 4,069 participants. Only 41.9% of the participants reported that their child(ren) had been infected with the coronavirus. 2.00 was the median number of children (IQR: 1.00–4.00). More than half of the study participants (64.2%) reported that a family member had been infected with the coronavirus. Both parents received COVID-19 vaccination, according to most participants (88.7%). Most participants (70.5%) stated that all children who met the vaccination criteria had received the vaccine. Most participants (83.5%) said their child or children had two doses of their vaccine, and about half (50.4%) of those who received the vaccine reported experiencing side effects. In addition, the majority (78.9%) reported that the side effects appeared within one day of receiving the vaccine, and nearly two-thirds (65.7%) reported that the side effects lasted between one and three. A total of 11,831 side effects cases were documented. Pain at the injection site, hyperthermia, and fatigue were the most reported side effects, accounting for 15.3%, 14.1%, and 13.2%, respectively. CONCLUSION: It appears that the side effects of the COVID-19 vaccine for children are minor, tolerable, and like those described previously in clinical trials. Our data should encourage the public about the safety of receiving the COVID-19 vaccine for children. BioMed Central 2022-12-06 /pmc/articles/PMC9724422/ /pubmed/36474174 http://dx.doi.org/10.1186/s12879-022-07905-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Alwafi, Hassan Naser, Abdallah Y. Aldhahir, Abdulelah M. Alhazmi, Ahmad Alosaimi, Areen Naif Mandili, Rasha Abdulaziz Majeed, Zaid Salawati, Emad Ekram, Rakan Samannodi, Mohammed Assaggaf, Hamza Almatrafi, Mohammed Alqahtani, Jaber S. Alsanosi, Safaa Mohammed Minshawi, Faisal COVID-19 vaccination side effects among the child age group: a large cross-sectional online based survey in Saudi Arabia |
title | COVID-19 vaccination side effects among the child age group: a large cross-sectional online based survey in Saudi Arabia |
title_full | COVID-19 vaccination side effects among the child age group: a large cross-sectional online based survey in Saudi Arabia |
title_fullStr | COVID-19 vaccination side effects among the child age group: a large cross-sectional online based survey in Saudi Arabia |
title_full_unstemmed | COVID-19 vaccination side effects among the child age group: a large cross-sectional online based survey in Saudi Arabia |
title_short | COVID-19 vaccination side effects among the child age group: a large cross-sectional online based survey in Saudi Arabia |
title_sort | covid-19 vaccination side effects among the child age group: a large cross-sectional online based survey in saudi arabia |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724422/ https://www.ncbi.nlm.nih.gov/pubmed/36474174 http://dx.doi.org/10.1186/s12879-022-07905-2 |
work_keys_str_mv | AT alwafihassan covid19vaccinationsideeffectsamongthechildagegroupalargecrosssectionalonlinebasedsurveyinsaudiarabia AT naserabdallahy covid19vaccinationsideeffectsamongthechildagegroupalargecrosssectionalonlinebasedsurveyinsaudiarabia AT aldhahirabdulelahm covid19vaccinationsideeffectsamongthechildagegroupalargecrosssectionalonlinebasedsurveyinsaudiarabia AT alhazmiahmad covid19vaccinationsideeffectsamongthechildagegroupalargecrosssectionalonlinebasedsurveyinsaudiarabia AT alosaimiareennaif covid19vaccinationsideeffectsamongthechildagegroupalargecrosssectionalonlinebasedsurveyinsaudiarabia AT mandilirashaabdulaziz covid19vaccinationsideeffectsamongthechildagegroupalargecrosssectionalonlinebasedsurveyinsaudiarabia AT majeedzaid covid19vaccinationsideeffectsamongthechildagegroupalargecrosssectionalonlinebasedsurveyinsaudiarabia AT salawatiemad covid19vaccinationsideeffectsamongthechildagegroupalargecrosssectionalonlinebasedsurveyinsaudiarabia AT ekramrakan covid19vaccinationsideeffectsamongthechildagegroupalargecrosssectionalonlinebasedsurveyinsaudiarabia AT samannodimohammed covid19vaccinationsideeffectsamongthechildagegroupalargecrosssectionalonlinebasedsurveyinsaudiarabia AT assaggafhamza covid19vaccinationsideeffectsamongthechildagegroupalargecrosssectionalonlinebasedsurveyinsaudiarabia AT almatrafimohammed covid19vaccinationsideeffectsamongthechildagegroupalargecrosssectionalonlinebasedsurveyinsaudiarabia AT alqahtanijabers covid19vaccinationsideeffectsamongthechildagegroupalargecrosssectionalonlinebasedsurveyinsaudiarabia AT alsanosisafaamohammed covid19vaccinationsideeffectsamongthechildagegroupalargecrosssectionalonlinebasedsurveyinsaudiarabia AT minshawifaisal covid19vaccinationsideeffectsamongthechildagegroupalargecrosssectionalonlinebasedsurveyinsaudiarabia |